Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 161 Lymphoid 68 Myeloid 31 Plasma cell 5 Sarcoma 2 Classical hematology 2 Tumor-Agnostic 1 Other neoplasm 1

Conditions

Interventions

pembrolizumab 24 Specimen Handling 22 Biopsy 22 Magnetic Resonance Spectroscopy 19 Paclitaxel 11 Standard of Care 10 Bevacizumab 10 atezolizumab 9 Carboplatin 9 Nivolumab 8 Cisplatin 8 Blood Specimen Collection 8 Surveys and Questionnaires 7 Capecitabine 7 Radiosurgery 6 Pemetrexed 6 Gemcitabine 6 Cyclophosphamide 6 durvalumab 5 Taxes 5 Irinotecan 5 trastuzumab deruxtecan 4 olaparib 4 niraparib 4 cabozantinib 4 X-Rays 4 Radiotherapy 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

venetoclax × Tumor-Agnostic × 90 days × Clear all

NCT03768063 2026-04-28

IMbrella B

Hoffmann-La Roche

Phase 3 Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡